Ascendis Pharma A/S Reports Third Quarter 2018 Financial Results

Oasmia intends to issue notice to an extraordinary general meeting at the request of a shareholder and announces that it is subject to legal proceedings with a major shareholder concerning the company’s warrants 2018/2019